Funding Received
$165 Million in 2 Rounds from 1 Investor
Most Recent Funding
$150 Million Debt Financing on April 7, 2014
Founded:
2010
Headquarters:
Richmond, VA
Description:
Intelliject, a specialty pharmaceutical company, develops combination drug products empowering patients to control their medical conditions.
Categories:
Biotechnology
Website:
http://kaleopharma.com

Detailed Description

Update

Intelliject is a specialty pharmaceutical company dedicated to developing combination drug/device products that empower patients to control and gain freedom from their medical conditions. Each Intelliject product in development combines an established drug, an innovative delivery platform and a supporting dossier intended to show superiority, patient preference and cost effectiveness data.

Intelliject applies rigorous selection criteria to identify areas where its patient-centric approach and proprietary technology will offer superior solutions. The company only proceeds to an active development program once it has established that incremental clinical and economic benefit is achievable. Intelliject has a focused pipeline of active programs across a number of therapeutic areas, including small molecules and biologics.

Current Team (8)

Update

Funding Rounds (2) - $165M

Update

Board Members and Advisors (2)

Update

Investors (1)

Update

Offices/Locations (1)

Update
  • Office

    111 Virginia St.

    Ste. 405

    Richmond, VA 23219

    USA

Images (1)

Update
  • 4718376c295cddde0344f7feb7876b3c